Found 21 matching trials
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting PHASE3 The goal of this clinical trial is to learn if medroxyprogesterone acetate ...
Show More Location
The First Affiliated Hospital of Xinxiang Medical University
Learn More & Join Trial
Emend for Multiple-day Emetogenic Chemotherapy PHASE2 The purpose of the study is to assess the effect of Emend (aprepitant) on n...
Show More Location
University of Illinois Medical Center
Learn More & Join Trial
Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study PHASE3 This is a multicenter, randomized, controlled, double-blind, phase III stud...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea PHASE4 The purpose of this study is to compare two different treatment protocols f...
Show More Location
Multiple Locations
Learn More & Join Trial
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles PHASE3 The name of this prospective study is a multicenter, open-label, randomized...
Show More Learn More & Join Trial
Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC PHASE3 The study is being conducted to evaluate the safety and efficacy of tisleli...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma PHASE1 Phase I: The primary purpose of this study phase is to determine the best d...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens PHASE3 The objective of this study is to compare the effectiveness of olanzapine a...
Show More Location
Augusta University Medical Center
Learn More & Join Trial
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting PHASE2 Chemotherapy-induced nausea and vomiting (CINV) adversely affects patients'...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study PHASE2 This prospective Phase II study aims to evaluate the efficacy and safety of...
Show More Location
Al Hussien University Hospital
Learn More & Join Trial